Skip to main content
Clinical Trials/NCT03573635
NCT03573635CompletedNot Applicable

Evaluation of the Effectiveness and Safety of an Own-invention System for Continuous Supraglottic Aspiration in Intubated and Mechanically Ventilated Patients: the "SUPRAtube" Device

Fundación Cardiovascular de Colombia2 sites in 1 country38 target enrollmentStarted: January 10, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
38
Locations
2
Primary Endpoint
aspirated secretions

Study Overview

Brief Summary

Purpose of the trial: Evaluate the efficacy and safety of the device of self-invention of continuous oropharyngeal aspiration denominated "SUPRAtube" in patients with orotracheal intubation and mechanical ventilation.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Endotracheal intubation and invasive mechanical ventilation,

Exclusion Criteria

  • Immediate postoperative oral cavity.
  • Traumatic oral cavity injury.
  • Platelet count less than 50000.

Arms & Interventions

Supratube

Other

Patient with orotracheal intubation and supratube device

Intervention: Supratube (Device)

Supratube

Other

Patient with orotracheal intubation and supratube device

Intervention: Reference (Other)

Outcomes

Primary Outcomes

aspirated secretions

Time Frame: 24 hours after intubation

volume of aspirated secretions

Secondary Outcomes

  • Adverse events(24 hours after intubation)

Investigators

Sponsor
Fundación Cardiovascular de Colombia
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials